Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controlsTravis T. Sims, Ann H. Klopp, Lauren E. Colbert et al.|Gynecologic Oncology|2019Cited by 110
A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancersMolly B. El Alam, Lauren E. Colbert, Travis Solley et al.|PLoS ONE|2021Cited by 38
Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational OpportunitiesAnne Knisely, Amir A. Jazaeri, Yibo Dai et al.|Clinical Cancer Research|2025Cited by 10
Compositional and temporal changes of the gut microbiome in women with cervical cancer undergoing chemoradiation: Does it predict response?Travis T. Sims, Ann H. Klopp, Lauren E. Colbert et al.|Gynecologic Oncology|2020Cited by 3
Uncovering mechanisms of response of pembrolizumab and lenvatinib for the treatment of platinum-resistant high grade serous ovarian cancer.Jeffrey How, Amir A. Jazaeri, Shannon N. Westin et al.|Journal of Clinical Oncology|2023Cited by 2